Dysregulation or deficiency of CD59 is implicated in several diseases. For instance, a deficiency in CD59 can lead to Paroxysmal Nocturnal Hemoglobinuria (PNH), a condition characterized by the destruction of red blood cells. Furthermore, aberrant expression of CD59 has been observed in various cancer types, where it may contribute to tumor immune evasion.
